Shalby

195.14
+2.53
(1.31%)
Market Cap
2,107.70 Cr
EPS
7.78
PE Ratio
61.39
Dividend Yield
0.62 %
52 Week High
325.00
52 Week Low
180.35
PB Ratio
2.06
Debt to Equity
0.29
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,077.40
#1 1,04,738.58
98.48
5,584.10
18.77
#1 1,058
-17.46
48.87
7,013.00
1,00,836.18
75.76
#1 19,165.50
14.74
917
49.14
67.35
649.55
49,038.31
64.05
6,931.20
8.99
645
#1 89.49
57.00
1,810.00
36,989.31
45.33
5,093.40
10.96
790
2.66
66.82
1,275.90
34,269.06
67.54
2,759.20
#1 25.09
326
15.71
59.81
645.30
25,820.97
72.52
2,511.20
12.94
336
20.76
59.67
498.85
24,918.21
93.24
3,723.70
22.85
205
-69.22
64.86
1,513.00
15,364.77
66.83
1,334.00
10.76
218
10.06
76.68
5,635.00
13,365.32
#1 29.61
599.90
11.69
58
8.85
53.98
1,437.00
9,421.84
49.27
1,095.50
21.32
177
20.14
38.77
Growth Rate
Revenue Growth
15.20 %
Net Income Growth
23.34 %
Cash Flow Change
-71.08 %
ROE
13.56 %
ROCE
9.78 %
EBITDA Margin (Avg.)
7.06 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
91
119
122
115
116
133
128
123
119
41
118
134
147
195
184
165
167
206
207
207
208
240
243
221
249
289
275
281
Expenses
64
91
97
93
98
102
98
99
106
43
86
101
114
154
152
139
139
162
165
169
173
192
185
174
205
234
235
242
EBITDA
27
27
25
22
17
31
30
24
13
-3
32
33
33
41
32
27
28
44
42
38
35
48
58
47
44
55
40
39
Operating Profit %
29 %
21 %
19 %
17 %
13 %
22 %
22 %
18 %
2 %
-13 %
26 %
23 %
21 %
20 %
16 %
15 %
15 %
20 %
18 %
17 %
13 %
18 %
22 %
20 %
16 %
16 %
12 %
12 %
Depreciation
4
8
8
9
8
9
9
9
9
9
9
9
9
9
12
11
11
12
12
12
13
12
12
12
16
16
17
16
Interest
4
2
2
2
3
1
1
2
2
1
1
1
1
1
2
2
2
2
2
3
3
3
3
4
7
8
9
11
Profit Before Tax
19
18
15
12
7
21
20
14
2
-13
22
23
23
31
19
14
15
31
29
24
19
33
43
31
22
30
14
12
Tax
4
6
11
-2
4
-3
7
6
19
-4
-3
6
13
11
8
1
5
11
10
8
5
12
15
12
6
16
11
15
Net Profit
15
12
4
13
3
24
13
8
-17
-9
25
17
10
20
11
13
10
20
18
15
14
21
28
19
16
15
2
-3
EPS in ₹
1.63
1.11
0.33
1.24
0.30
2.19
1.20
0.75
-1.58
-0.81
2.27
1.56
0.91
1.87
0.99
1.20
0.94
1.87
1.71
1.42
1.29
1.94
2.57
1.78
1.49
1.37
0.22
-0.28

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
679
961
939
967
997
1,194
1,281
1,608
Fixed Assets
323
650
692
673
660
675
685
966
Current Assets
89
212
197
234
271
449
517
552
Capital Work in Progress
221
47
3
6
8
6
11
15
Investments
0
0
11
28
16
25
146
81
Other Assets
135
264
233
260
314
488
440
545
Total Liabilities
679
961
939
967
997
1,194
1,281
1,608
Current Liabilities
130
115
88
83
82
173
194
323
Non Current Liabilities
298
95
71
84
80
145
159
277
Total Equity
251
752
780
799
835
876
928
1,008
Reserve & Surplus
164
643
672
691
727
768
820
893
Share Capital
87
108
108
108
108
108
107
107

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
22
-19
3
0
-6
3
-2
49
-43
15
Investing Activities
-62
-98
-153
-236
1
-31
-51
-60
-61
146
Operating Activities
123
5
61
14
43
55
79
19
68
20
Financing Activities
-39
75
96
222
-51
-22
-30
91
-50
-151

Share Holding

% Holding
Mar 2021
May 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
79.45 %
74.07 %
74.07 %
74.02 %
74.02 %
74.02 %
74.04 %
74.04 %
74.12 %
74.12 %
74.12 %
74.12 %
74.12 %
74.24 %
74.25 %
74.25 %
74.27 %
74.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.11 %
4.62 %
4.88 %
5.35 %
5.37 %
4.65 %
4.54 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.09 %
0.14 %
0.18 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.68 %
11.97 %
11.14 %
11.16 %
12.03 %
11.86 %
11.91 %
11.95 %
11.06 %
11.13 %
11.28 %
11.35 %
10.66 %
10.40 %
9.97 %
10.09 %
10.78 %
10.67 %
Others
8.86 %
13.96 %
14.79 %
14.82 %
13.95 %
14.13 %
14.06 %
14.01 %
14.76 %
14.75 %
14.59 %
10.42 %
10.60 %
10.49 %
10.37 %
10.20 %
10.16 %
10.34 %
No of Share Holders
55,974
54,939
52,524
53,854
55,562
55,233
54,666
54,537
52,775
52,181
52,580
50,225
49,495
49,858
49,315
51,479
52,328
52,895

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.5 0.5 1 1 1.2 1.2 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.08 0.5 0.85 0.77 0.5 0.61 0.00

Corporate Action

Announcements

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A6 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
Disclosure Under Reg. 31(4) Of SEBI (SAST) Regulations 2011Apr 04, 2025
Disclosure Under Reg. 31(4) Of SEBI (SAST) Regulations 2011Apr 04, 2025
Allotment Of Equity Shares By Wholly Owned Subsidiary Shalby Medtech Ltd To Shalby LtdMar 28, 2025
Termination Of Franchise Agreement RanchiMar 25, 2025
Closure of Trading WindowMar 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 15, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 04, 2025
Receipt Of Hand Transplant ApprovalFeb 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 10, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 07, 2025
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 03, 2025
Integrated Filing (Financial)Feb 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd February 2025Feb 03, 2025
Unaudited Standalone And Consolidated Financial Results For Quarter Ended December 31 2024Feb 03, 2025
Update on board meetingJan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024 And Other Business MattersJan 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 16, 2025
Inauguration Of Shalby Tissue & Bone Bank At Krishna Shalby Hospital AhmedabadJan 16, 2025
Shalby Advanced Technologies (SAT) Inc. USA Received US FDA Approval For Its ProductJan 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 03, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 28, 2024
Disclosure Under Regulation 29(2) Of Securities Exchange Board Of India (Substantial Acquisition Of Shares And Takeover) Regulations, 2011Nov 15, 2024
Disclosure Under Regulation 7(2) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015Nov 15, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 30, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 30, 2024
Board Meeting Outcome for Outcome Of Board MeetingOct 30, 2024
Unaudited Financials Results For Q2 & H1 FY25Oct 30, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 24, 2024
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended 30Th September 2024 And Other Business MattersOct 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Shalby Sanar International Hospitals Honored With AACI International AccreditationOct 03, 2024
Shalby Multispecialty Hospital Honored With Prestigious 'Best Hospital Chain Of The Year (West) By Economic Times Healthcare Awards 2024Sep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024

Technical Indicators

RSI(14)
Neutral
45.20
ATR(14)
Less Volatile
9.35
STOCH(9,6)
Oversold
19.57
STOCH RSI(14)
Oversold
15.49
MACD(12,26)
Bearish
-0.88
ADX(14)
Weak Trend
11.32
UO(9)
Bearish
37.41
ROC(12)
Downtrend And Accelerating
-2.87
WillR(14)
Neutral
-68.79